GRIFONI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.509
EU - Europa 1.257
AS - Asia 230
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.502
PL - Polonia 500
IE - Irlanda 215
IT - Italia 172
SE - Svezia 161
HK - Hong Kong 104
DE - Germania 103
CN - Cina 69
FI - Finlandia 40
GB - Regno Unito 28
JO - Giordania 18
VN - Vietnam 16
ES - Italia 14
SG - Singapore 9
TR - Turchia 8
CA - Canada 7
RU - Federazione Russa 6
BE - Belgio 5
IN - India 5
UA - Ucraina 4
CH - Svizzera 3
NL - Olanda 3
RO - Romania 2
AP - ???statistics.table.value.countryCode.AP??? 1
EU - Europa 1
FR - Francia 1
JP - Giappone 1
Totale 3.998
Salva come PNG Salva come JPEG
Città #
Warsaw 500
Fairfield 466
Ashburn 235
Woodbridge 219
Dublin 215
Chandler 203
Seattle 191
Cambridge 185
Wilmington 163
Houston 160
Ann Arbor 80
Lawrence 76
Princeton 72
Altamura 71
Hong Kong 54
Beijing 51
Buffalo 51
Medford 42
Florence 41
San Diego 25
Boston 20
Jacksonville 17
Barcelona 14
Falls Church 14
Dong Ket 10
New York 10
Singapore 9
Boardman 8
Shanghai 8
Izmir 6
London 6
Moscow 6
Nürnberg 6
Brussels 5
Norwalk 5
Phoenix 5
Toronto 5
Cagliari 4
Castelliri 4
Milan 4
Pune 4
Redmond 4
Andover 3
Bern 3
Dearborn 3
Düsseldorf 3
Guangzhou 3
Nanjing 3
Redwood City 3
Bari 2
Chicago 2
Hillsboro 2
Hounslow 2
Kilburn 2
Nanchang 2
Scandicci 2
Siena 2
Velletri 2
Bolano 1
Brampton 1
Bremen 1
Castelnuovo 1
Cinisello Balsamo 1
Colle Di Val D'elsa 1
Corsico 1
Dallas 1
Duncan 1
Esslingen am Neckar 1
Falkenstein 1
Filottrano 1
Fuzhou 1
Groningen 1
Hyderabad 1
Los Angeles 1
Massarosa 1
Mcallen 1
Misano Adriatico 1
Montréal 1
Munich 1
Nagold 1
Old Bridge 1
Rimini 1
Rome 1
Rotterdam 1
Salerno 1
San Jose 1
Sassoferrato 1
Torino 1
Washington 1
Zhengzhou 1
Totale 3.345
Salva come PNG Salva come JPEG
Nome #
Searching for a common mechanism for placenta mediated pregnancy complications and cardiovascular disease: role of Lipoprotein (a) 295
Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion 234
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment 190
Metabolomics by Nuclear Magnetic Resonance identifies patients with high risk of death within two years after a cardiovascular event: The case of the amiflorence II study 147
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 115
Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system 115
Different NT-proBNP circulating levels for different types of cardiac amyloidosis 112
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 111
The platypnea-orthodeoxia syndrome: an unusual case of dyspnea 99
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism. 96
Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM study 96
High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI 88
Direct oral anticoagulants in the early phase of non-valvular atrial fibrillation-related ischemic stroke in very old patients undergoing systemic thrombolysis and/or mechanical thrombectomy 85
Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention. 83
Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. 82
Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled: An italian experience 82
Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years 81
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting 78
On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty 75
Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome 75
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 74
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism 74
Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation 73
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism 72
Sharing data of clinical trials 72
Retinal vein occlusions: a review for the internist 71
Central nervous system hemangiopericytoma with bone and lung metastases: a case report. 71
A case of persistent hiccup after laparoscopic cholecystectomy. 66
Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity 65
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants 63
Risk of recurrence in patients with pulmonary embolism: Predictive role of D-dimer and of residual perfusion defects on lung scintigraphy. 61
The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant 60
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants 59
The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism. 58
On-treatment platelet reactivity: State of the art and perspectives 58
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study 57
Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population 55
Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic stroke 54
The role of D-dimer testing in patients with suspected venous thromboembolism 53
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study 50
Funzione piastrinica e rischio di eventi avversi in pazienti con arteriopatia periferica sottoposti a rivascolarizzazione percutanea (Platelet function and risk of adverse events in peripheral artery disease patients undergoing percutaneous revascularization). 49
Hypokalemia-induced rhabdomyolysis. 46
Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion 42
Confidence in the Use of Direct Oral Anticoagulants in the Acute Phase of Nonvalvular Atrial Fibrillation–Related Ischemic Stroke Over the Years: A Real-World Single-Center Study 39
Capitolo 38: Anomalie della fibrinolisi e trombosi 38
The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience 38
Homocysteine plasma levels influence impaired fibrinolitic capacity but not in vitro cleavage of fibrin by exogenous plasmin in patients with Pulmonary Embolism 35
Hypofibrinolysis accounts only in part for alteration of clot lysis time in patients with prior pulmonary embolism without pulmonary hypertension 32
[Stroke risk stratification in atrial fibrillation: oral anticoagulant therapy and bleeding risk in the elderly] 29
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study 27
Poststroke Detection of Subclinical Paroxysmal Atrial Fibrillation in Patients With Embolic Stroke of Undetermined Source in the Real World Practice: The Empoli ESUS Atrial Fibrillation (E2AF) Study 25
Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin k antagonists: Results of epica study on the behalf of FCSA (italian federation of anticoagulation clinics) 24
Interleukin-6 as prognosticator in patients with COVID-19 18
Interleukin-6 added to CALL score better predicts the prognosis of COVID-19 patients 15
Predictive Factors for Hemorrhagic Transformation in Acute Ischemic Stroke in the REAL-World Clinical Practice 13
Prognostic determinants in patients with non traumatic intracerebral hemorrhage: a real life report 12
Totale 4.087
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019325 0 0 0 0 0 0 0 0 0 0 166 159
2019/2020971 81 52 29 70 113 116 128 115 109 66 65 27
2020/2021639 41 43 56 87 32 74 47 40 68 80 34 37
2021/2022374 13 25 34 9 5 27 10 24 14 29 73 111
2022/2023936 99 226 40 63 44 164 132 49 78 4 25 12
2023/2024280 11 36 56 15 24 41 16 69 8 4 0 0
Totale 4.087